Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-002666
Filing Date
2025-01-27
Accepted
2025-01-27 17:12:21
Documents
1
Period of Report
2025-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1738015934.html 4  
1 FORM 4 wk-form4_1738015934.xml 4 3471
  Complete submission text file 0001628280-25-002666.txt   5099
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MADRIGAL PHARMACEUTICALS, INC., FOUR TOWER BRIDGE, 200 BARR HARBOR DR STE 200 WEST CONSHOHOCKEN PA 19428
Business Address
Sibold William John (Reporting) CIK: 0001518611 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 25560027